CarraShield Labs

CarraShield Labs (CSL) has developed and patented a personal lubricant technology based on a long chain polysaccharide molecule derived from special sea algae extract called CarraShield, contained in their Divine 9 brand.  The growing body of research supports the fact it creates an environment not conducive to human papillomavirus variants. The most recent and compelling research has been led by a highly credentialed team at the McGill University Medical School. Results from the world's first human clinical trial involving hundreds of women show that the CarraShield gel reduced the likelihood of HPV infection as compared to a placebo lubricant. The HPV prevention characteristics of CarraShield gel have been previously validated by series of laboratory studies at the National Cancer Institute, Albert Einstein College of Medicine and Rutgers University Medical School.